Caudalie partners with Harvard University for a new patent

By

Sarah Ahssen

Published
Aug 4, 2015

The French cosmetics label, founded by Mathilde and Bertrand Thomas and soon to celebrate its 20th anniversary, has recently registered a patent together with Harvard University regarding a new anti-ageing technology.

Research carried out by Dr David Sinclair's laboratory at Harvard Medical School (HMS) has demonstrated a synergy between resveratrol, chiefly present in vine shoots, and a hyaluronic acid micro-complex. This association stimulates the HAS2 gene and actually allows the production of natural hyaluronic acid, but also that of collagen and elastin.
 
This research is protected by a patent registered jointly by Caudalie's researchers and the Office of Technology Development (OTD) at Harvard University, who have granted Caudalie the exclusive right to use the patent in the cosmetics, dietary supplements and cosmetic injections sectors. The research has led to the creation of the new Resveratrol Lift anti-ageing line.

The range features four products: a serum (€45 for 30 ml), a night cream, a firming fluid and an eye-firming balm (€34 for 15 ml). The line will replace the Vinexpert product range in October. For its part, Caudalie spas will offer a face treatment cream derived from this new range.
 
On July 8th, at the press conference for the launch of Resveratrol Lift, Mathilde Thomas also announced that, after living in New York for five years, she will move be moving with her family to Hong Kong. Caudalie thereby wishes to develop in Asia.